FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210974312> ?p ?o ?g. }

• W3210974312 endingPage "453" @default.
• W3210974312 startingPage "446" @default.
• W3210974312 abstract "Studies evaluating neutralizing antibody (NAb) after BNT162b2 vaccine are scarce. We therefore compared NAb using the plaque reduction neutralization test (PRNT) in vaccinated subjects, with those from five chemiluminescent (CLIA) assays, two targeting ACE and S-RBD interaction. Sera from 174 completely Comirnaty/BNT162b2 vaccinated healthcare workers (HCW) were evaluated at t12 and t28. NAb titers at low (PRNT50) or high (PRNT90) stringency were compared with: Liaison SARS-CoV-2 Trimeric-S IgG, Elecsys S-RBD Ab, Maglumi SARS-CoV-2 S-RBD IgG and SARS-CoV-2 Nab; iFlash 2019-nCoV NAb. Neither PRNT50 nor PRNT90 correlated with age (range, 24–65 years); no significant differences were found for gender. PRNT50 and PRNT90 seropositive titers (≥1:20) were 43 (24.7%) and 15 (8.6%) at t12 and 167 (95.9%) and 149 (85.6%) at t28. CLIA results at t28 were uncorrelated with age, apart from Elecsys S-RBD Ab (r = -0.164, p = 0.046). Gender differences were found for Maglumi SARS-CoV-2 S-RBD IgG (p = 0.037) and Maglumi NAb (p = 0.046). Considering PRNT50 at thresholds of 1:20 (or 1:40) and 1:160 (or 1:320), corresponding to different immune protective levels, CLIA cut-offs have been identified. Comirnaty/BNT162b2 elicits strong NAb production, especially 28 days after first inoculum. Differences in correlation between Nab titers and circulating antibodies measured by 5 immunoassays have been found, being stronger the correlation for Maglumi Nab." @default.
• W3210974312 created "2021-11-08" @default.
• W3210974312 creator A5018059398 @default.
• W3210974312 creator A5018143293 @default.
• W3210974312 creator A5037249662 @default.
• W3210974312 creator A5039768213 @default.
• W3210974312 creator A5039932423 @default.
• W3210974312 creator A5042444993 @default.
• W3210974312 creator A5048422182 @default.
• W3210974312 creator A5064239979 @default.
• W3210974312 creator A5066920522 @default.
• W3210974312 creator A5067293143 @default.
• W3210974312 creator A5081456760 @default.
• W3210974312 creator A5083395862 @default.
• W3210974312 creator A5088323703 @default.
• W3210974312 date "2021-12-01" @default.
• W3210974312 modified "2023-10-17" @default.
• W3210974312 title "SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays" @default.
• W3210974312 cites W3031733179 @default.
• W3210974312 cites W3097453900 @default.
• W3210974312 cites W3111255098 @default.
• W3210974312 cites W3119858919 @default.
• W3210974312 cites W3129580280 @default.
• W3210974312 cites W3134663922 @default.
• W3210974312 cites W3137970801 @default.
• W3210974312 cites W3153468502 @default.
• W3210974312 cites W3159645562 @default.
• W3210974312 cites W3163785571 @default.
• W3210974312 cites W3172785218 @default.
• W3210974312 cites W3172812363 @default.
• W3210974312 cites W3173738234 @default.
• W3210974312 cites W3174585206 @default.
• W3210974312 cites W3174932895 @default.
• W3210974312 cites W3176668337 @default.
• W3210974312 cites W3177892074 @default.
• W3210974312 cites W3182514649 @default.
• W3210974312 cites W3182882252 @default.
• W3210974312 cites W3192243977 @default.
• W3210974312 cites W3195580372 @default.
• W3210974312 cites W3195915398 @default.
• W3210974312 cites W4225489846 @default.
• W3210974312 doi "https://doi.org/10.1016/j.cca.2021.10.028" @default.
• W3210974312 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8553360" @default.
• W3210974312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34755646" @default.
• W3210974312 hasPublicationYear "2021" @default.
• W3210974312 type Work @default.
• W3210974312 sameAs 3210974312 @default.
• W3210974312 citedByCount "17" @default.
• W3210974312 countsByYear W32109743122021 @default.
• W3210974312 countsByYear W32109743122022 @default.
• W3210974312 countsByYear W32109743122023 @default.
• W3210974312 crossrefType "journal-article" @default.
• W3210974312 hasAuthorship W3210974312A5018059398 @default.
• W3210974312 hasAuthorship W3210974312A5018143293 @default.
• W3210974312 hasAuthorship W3210974312A5037249662 @default.
• W3210974312 hasAuthorship W3210974312A5039768213 @default.
• W3210974312 hasAuthorship W3210974312A5039932423 @default.
• W3210974312 hasAuthorship W3210974312A5042444993 @default.
• W3210974312 hasAuthorship W3210974312A5048422182 @default.
• W3210974312 hasAuthorship W3210974312A5064239979 @default.
• W3210974312 hasAuthorship W3210974312A5066920522 @default.
• W3210974312 hasAuthorship W3210974312A5067293143 @default.
• W3210974312 hasAuthorship W3210974312A5081456760 @default.
• W3210974312 hasAuthorship W3210974312A5083395862 @default.
• W3210974312 hasAuthorship W3210974312A5088323703 @default.
• W3210974312 hasBestOaLocation W32109743121 @default.
• W3210974312 hasConcept C116675565 @default.
• W3210974312 hasConcept C126322002 @default.
• W3210974312 hasConcept C145802702 @default.
• W3210974312 hasConcept C159047783 @default.
• W3210974312 hasConcept C159654299 @default.
• W3210974312 hasConcept C178790620 @default.
• W3210974312 hasConcept C185592680 @default.
• W3210974312 hasConcept C203014093 @default.
• W3210974312 hasConcept C2779134260 @default.
• W3210974312 hasConcept C2779261636 @default.
• W3210974312 hasConcept C3006700255 @default.
• W3210974312 hasConcept C3007834351 @default.
• W3210974312 hasConcept C3008058167 @default.
• W3210974312 hasConcept C32611913 @default.
• W3210974312 hasConcept C524204448 @default.
• W3210974312 hasConcept C71924100 @default.
• W3210974312 hasConceptScore W3210974312C116675565 @default.
• W3210974312 hasConceptScore W3210974312C126322002 @default.
• W3210974312 hasConceptScore W3210974312C145802702 @default.
• W3210974312 hasConceptScore W3210974312C159047783 @default.
• W3210974312 hasConceptScore W3210974312C159654299 @default.
• W3210974312 hasConceptScore W3210974312C178790620 @default.
• W3210974312 hasConceptScore W3210974312C185592680 @default.
• W3210974312 hasConceptScore W3210974312C203014093 @default.
• W3210974312 hasConceptScore W3210974312C2779134260 @default.
• W3210974312 hasConceptScore W3210974312C2779261636 @default.
• W3210974312 hasConceptScore W3210974312C3006700255 @default.
• W3210974312 hasConceptScore W3210974312C3007834351 @default.
• W3210974312 hasConceptScore W3210974312C3008058167 @default.
• W3210974312 hasConceptScore W3210974312C32611913 @default.
• W3210974312 hasConceptScore W3210974312C524204448 @default.
• W3210974312 hasConceptScore W3210974312C71924100 @default.

• next